DILATREND

Dilatrend Adverse Events Reported to the FDA Over Time

How are Dilatrend adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Dilatrend, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Dilatrend is flagged as the suspect drug causing the adverse event.

Most Common Dilatrend Adverse Events Reported to the FDA

What are the most common Dilatrend adverse events reported to the FDA?

Death	34 (4.85%)
Hypotension	30 (4.28%)
Bradycardia	24 (3.42%)
Loss Of Consciousness	16 (2.28%)
Drug Interaction	14 (2%)
Hypoglycaemia	14 (2%)
Asthenia	13 (1.85%)
Dyspnoea	13 (1.85%)
Cardiac Arrest	11 (1.57%)
Dizziness	11 (1.57%)
Cardiac Failure	10 (1.43%)
	Show More
Syncope	8 (1.14%)
Vertigo	8 (1.14%)
Abdominal Pain	7 (1%)
Atrial Fibrillation	7 (1%)
Fall	7 (1%)
Psoriasis	7 (1%)
Somnolence	7 (1%)
Hyperkalaemia	6 (.86%)
Nausea	6 (.86%)
Renal Failure	6 (.86%)
Sinus Bradycardia	6 (.86%)
Urticaria	6 (.86%)
Circulatory Collapse	5 (.71%)
Dehydration	5 (.71%)
Diarrhoea	5 (.71%)
Malaise	5 (.71%)
Muscular Weakness	5 (.71%)
Vision Blurred	5 (.71%)
Vomiting	5 (.71%)
Abdominal Pain Upper	4 (.57%)
Bronchospasm	4 (.57%)
Depression	4 (.57%)
Disease Progression	4 (.57%)
Hallucination	4 (.57%)
Hyperhidrosis	4 (.57%)
Hypothermia	4 (.57%)
Macular Degeneration	4 (.57%)
Myocardial Infarction	4 (.57%)
Oedema Peripheral	4 (.57%)
Retinal Oedema	4 (.57%)
Transplant Rejection	4 (.57%)
Abnormal Behaviour	3 (.43%)
Anaphylactic Reaction	3 (.43%)
Asthma	3 (.43%)
Atrioventricular Block	3 (.43%)
Blood Pressure Decreased	3 (.43%)
Bone Marrow Failure	3 (.43%)
Cardiac Failure Congestive	3 (.43%)
Confusional State	3 (.43%)
Delirium	3 (.43%)
Dermatitis Allergic	3 (.43%)
Electrocardiogram Qt Prolonged	3 (.43%)
Extrasystoles	3 (.43%)
Fatigue	3 (.43%)
Fluid Retention	3 (.43%)
General Physical Health Deteriorati...	3 (.43%)
Hepatocellular Injury	3 (.43%)
Hypertension	3 (.43%)
Hypoaesthesia	3 (.43%)
Hypoglycaemic Coma	3 (.43%)
Neutrophilia	3 (.43%)
Orthopnoea	3 (.43%)
Orthostatic Hypotension	3 (.43%)
Presyncope	3 (.43%)
Rash	3 (.43%)
Rhabdomyolysis	3 (.43%)
Stridor	3 (.43%)
Suicidal Ideation	3 (.43%)
Thrombocytopenia	3 (.43%)
Visual Impairment	3 (.43%)
White Blood Cell Count Increased	3 (.43%)
Anaemia	2 (.29%)
Angiopathy	2 (.29%)
Atrioventricular Block Second Degre...	2 (.29%)
Back Disorder	2 (.29%)
Blood Cholesterol Increased	2 (.29%)
Cardiovascular Disorder	2 (.29%)
Chronic Myeloid Leukaemia	2 (.29%)
Condition Aggravated	2 (.29%)
Corneal Disorder	2 (.29%)
Cough	2 (.29%)
Drug Administration Error	2 (.29%)
Drug Exposure During Pregnancy	2 (.29%)
Drug Intolerance	2 (.29%)
Dysuria	2 (.29%)
Erythema	2 (.29%)
Erythropenia	2 (.29%)
Eye Irritation	2 (.29%)
Feeling Abnormal	2 (.29%)
Fluid Overload	2 (.29%)
Haemorrhage	2 (.29%)
Headache	2 (.29%)
Hepatic Encephalopathy	2 (.29%)
Hepatic Function Abnormal	2 (.29%)
Incontinence	2 (.29%)
Incorrect Dose Administered	2 (.29%)
Insomnia	2 (.29%)
Intentional Overdose	2 (.29%)
Intracranial Haematoma	2 (.29%)
Keratoconjunctivitis Sicca	2 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Dilatrend, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dilatrend is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Dilatrend

What are the most common Dilatrend adverse events reported to the FDA?

Cardiac Arrhythmias	66 (9.42%)
Neurological	59 (8.42%)
Decreased And Nonspecific Blood Pre...	39 (5.56%)
Fatal Outcomes	35 (4.99%)
Respiratory	29 (4.14%)
Epidermal And Dermal Conditions	27 (3.85%)
Gastrointestinal Signs	23 (3.28%)
Glucose Metabolism Disorders	17 (2.43%)
Therapeutic And Nontherapeutic Effe...	17 (2.43%)
Electrolyte And Fluid Balance Condi...	16 (2.28%)
Heart Failures	16 (2.28%)
	Show More
Muscle	12 (1.71%)
Vision	11 (1.57%)
Medication Errors	10 (1.43%)
Renal Disorders	10 (1.43%)
Cardiac And Vascular Investigations	9 (1.28%)
Coronary Artery	9 (1.28%)
Injuries	9 (1.28%)
Inner Ear And Viiith Cranial Nerve	8 (1.14%)
Lower Respiratory Tract Disorders	8 (1.14%)
Anemias Nonhemolytic And Marrow Dep...	7 (1%)
Bronchial Disorders	7 (1%)
Hematology Investigations	7 (1%)
Hepatic And Hepatobiliary	7 (1%)
Ocular Infections, Irritations And ...	7 (1%)
Angiedema And Urticaria	6 (.86%)
Body Temperature Conditions	6 (.86%)
Deliria	6 (.86%)
Musculoskeletal And Connective Tiss...	6 (.86%)
Sleep Disorders	6 (.86%)
Urinary Tract Signs	6 (.86%)
White Blood Cell	6 (.86%)
Depressed Mood Disorders	5 (.71%)
Disturbances In Thinking	5 (.71%)
Eye	5 (.71%)
Gastrointestinal Motility And Defec...	5 (.71%)
Vascular	5 (.71%)
Allergic Conditions	4 (.57%)
Cardiac Disorder Signs	4 (.57%)
Hepatobiliary	4 (.57%)
Immune	4 (.57%)
Ocular Structural Change, Deposit A...	4 (.57%)
Skin Appendage Conditions	4 (.57%)
Suicidal And Self-injurious Behavio...	4 (.57%)
Arteriosclerosis, Stenosis, Vascula...	3 (.43%)
Bone And Joint Injuries	3 (.43%)
Chemical Injury And Poisoning	3 (.43%)
Embolism And Thrombosis	3 (.43%)
Enzyme	3 (.43%)
Infections - Pathogen Unspecified	3 (.43%)
Lipid Analyses	3 (.43%)
Movement Disorders	3 (.43%)
Platelet	3 (.43%)
Psychiatric And Behavioural Symptom...	3 (.43%)
Red Blood Cell	3 (.43%)
Renal And Urinary Tract Investigati...	3 (.43%)
Skin Vascular Abnormalities	3 (.43%)
Upper Respiratory Tract Disorders	3 (.43%)
Vascular Hypertensive	3 (.43%)
Anxiety Disorders	2 (.29%)
Breast Neoplasms Malignant And Unsp...	2 (.29%)
Central Nervous System Vascular	2 (.29%)
Encephalopathies	2 (.29%)
Gastrointestinal Hemorrhages	2 (.29%)
Headaches	2 (.29%)
Leukemias	2 (.29%)
Physical Examination Topics	2 (.29%)
Seizures	2 (.29%)
Toxicology And Therapeutic Drug Mon...	2 (.29%)
Vascular Hemorrhagic	2 (.29%)
Water, Electrolyte And Mineral	2 (.29%)
Anal And Rectal Conditions	1 (.14%)
Bacterial Infectious	1 (.14%)
Bone Disorders	1 (.14%)
Cranial Nerve Disorders	1 (.14%)
Economic And Housing Issues	1 (.14%)
Gastrointestinal	1 (.14%)
Gastrointestinal Conditions	1 (.14%)
Gastrointestinal Stenosis And Obstr...	1 (.14%)
Gastrointestinal Ulceration And Per...	1 (.14%)
Genitourinary Tract	1 (.14%)
Hemolyses And Related Conditions	1 (.14%)
Lifestyle Issues	1 (.14%)
Lipid Metabolism	1 (.14%)
Maternal Complications Of Labour An...	1 (.14%)
Maternal Complications Of Pregnancy	1 (.14%)
Mental Impairment	1 (.14%)
Miscellaneous And Site Unspecified ...	1 (.14%)
Myocardial	1 (.14%)
Neonatal And Perinatal Conditions	1 (.14%)
Neuromuscular	1 (.14%)
Ocular Neuromuscular	1 (.14%)
Penile And Scrotal Disorders	1 (.14%)
Pericardial	1 (.14%)
Retina, Choroid And Vitreous Hemorr...	1 (.14%)
Sexual Function And Fertility	1 (.14%)
Uterine, Pelvic And Broad Ligament	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Dilatrend, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dilatrend is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.